Rifampin is a medication used in the management and treatment of various mycobacterial and gram-positive bacterial infections. It belongs to the antimicrobial class of drugs. This activity describes the indications, action, and contraindications for rifampin as a valuable agent in managing tuberculosis, leprosy, and serious gram-positive infections, including MRSA. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions) pertinent to members of the healthcare team in the management of patients with tuberculosis and related conditions.

**Objectives:**
- Identify the mechanism of action of rifampin.
- Describe the potential adverse effects of rifampin.
- Review the appropriate monitoring for patients receiving antimicrobial therapy with rifampin.
- Outline the interprofessional team strategies for improving care coordination and communication to advance rifampin and improve outcomes.